Best Practice & Research Clinical Haematology
Volume 21, Issue 3 , Pages 405-420, September 2008

Immunotherapy targeting EBV-expressing lymphoproliferative diseases

  • Helen E. Heslop, MBChB, MD (Professor of Medicine and Pediatrics)

      Affiliations

    • Corresponding Author InformationCorresponding author. Center for Cell and Gene Therapy, 1102 Bates St, Suite 1120, Houston, TX 77030, USA. Tel.: +1 832 824 4662; Fax: +1 832 825 4668.

Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital, Houston, TX, USA

University of Texas MD Anderson Cancer Center, Houston, TX, USA

Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital, Houston, TX, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(08)00053-4

doi:10.1016/j.beha.2008.06.002

Best Practice & Research Clinical Haematology
Volume 21, Issue 3 , Pages 405-420, September 2008

Article Tools

* Image Usage & Resolution